TOP

About Us

  • About Us
  • Company History

Company History

2022
December
Formed a crucial partnership by signing a Memorandum of Understanding (MOU)
with the KAIST-Wonjin Cell Therapy Center.
2022
November
Initiated preclinical studies for our promising CTXPD-01 project, marking a
significant milestone in our research and development journey.
2022
August
Recognized for our rigorous research standards with the issuance of an Affiliated
Research Institute certificate.
2022
April
Attracted key funding in our Pre-Series A round, led by Dasan Ventures, propelling
our groundbreaking research further.
2021
December
Welcomed Seong Won Ahn as our dynamic CEO, bringing fresh leadership and
strategic vision to our team.
2021
September
Strengthened our research and development team with the appointment of
Namshik Kim as the director of the research institute and Chief Technology
Officer (CTO).
2021
May

Proudly marked the establishment of CTX Inc., laying the foundation for our
innovative work in cell therapy.

Entrusted leadership to Wonjin Park as the CEO, whose guidance has been integral
to our success.

2021
February
Began our inspiring journey by agreeing to a generous donation and investment
from the KAIST-Wonjin Cell Therapy Center. This marked the genesis of our
commitment to revolutionizing cell therapy.

  • Address05854 B1209, 114 Beobwon-ro, Songpa-gu, Seoul, Korea
  • Tel02-6214-7740
  • Fax02-6214-7747
  • E-mailctx@cell-tx.com

Copyright(c) CTX Inc. All right reserved.